Merck Stock Up On Q2 Earnings Beat, Pfizer Revenue Declines On Falling Covid Vaccine Demand

Merck stock up on Q2 earnings beat, Pfizer revenue declines on falling COVID vaccine demand

Merck, Pfizer post earnings beats

CNBC Television

Merck, Pfizer stocks under pressure after reporting earnings

Merck stock pops on earnings beat, COVID treatment sales

Pfizer, Merck both post earnings beats

CNBC Television

Pfizer beats EPS estimates; stock falls on lower yearly guidance

CNBC Television

Merck CEO Rob Davis on Q2 results: We continue to see phenomenal growth

CNBC Television

Pfizer Q2 earnings: $0.78 per share vs $0.66 EPS expected

CNBC Television

Pfizer beats estimates for COVID-19 vaccine sales, misses on earnings

Pfizer reports first-quarter earnings, records $13.2 billion in Covid vaccine revenue

CNBC Television

Pfizer beats earnings estimates as declining Covid business performs better than expected

CNBC Television

Merck earnings beat estimates, narrows Covid pill sales forecast

CNBC Television

Pfizer reports revenue miss, weaker than expected COVID-19 vaccine sales forecast

Merck beats earnings expectations, raises sales outlook on strong demand for top drugs like Keytruda

CNBC Television

Moderna stock gets boost from earnings beat, COVID-19 vaccine sales

Merck earnings beat on top and bottom lines, raises forecast

CNBC Television

Pfizer beats on Q4 earnings, issues weak guidance for COVID-19 vaccine

Merck beats earnings estimates

CNBC Television

Here's a breakdown of Big Pharma earnings from Merck, Pfizer, Eli Lilly

CNBC Television

Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales

CNBC Television